PBSV vs LLY: Which Stock is Better?

Side-by-side comparison of Pharma-Bio Serv, Inc. and Eli Lilly & Co in 2026

Comparison Updated:

PBSV

Pharma-Bio Serv, Inc.

$0.50

LLY

Eli Lilly & Co

$927.03

Key Metrics Comparison

MetricPBSVLLYWinner
Market Cap$11.45M$829.71BLLY
P/E RatioN/A40.38LLY
EPS (TTM)$N/A$22.96LLY
Revenue Growth-0.1%0.4%LLY
Gross Margin32.5%83.0%LLY

Analyze PBSV

Full quant analysis

Analyze LLY

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is PBSV or LLY a better investment?

Comparing PBSV and LLY: Pharma-Bio Serv, Inc. has a market cap of $11.45M while Eli Lilly & Co has $829.71B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between PBSV and LLY?

PBSV (Pharma-Bio Serv, Inc.) and LLY (Eli Lilly & Co) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: PBSV or LLY?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: PBSV or LLY?

LLY has higher revenue growth at 0.4% vs -0.1% for PBSV.

Which company is more profitable: PBSV or LLY?

Eli Lilly & Co (LLY) has higher gross margins at 83.0% compared to 32.5% for PBSV.

Which is the larger company: PBSV or LLY?

Eli Lilly & Co (LLY) is larger with a market cap of $829.71B compared to $11.45M for PBSV.

Should I buy PBSV or LLY in 2026?

Both PBSV and LLY have investment merit. PBSV trades at $0.50 while LLY trades at $927.03. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between PBSV and LLY stock?

Key differences: Market Cap ($11.45M vs $829.71B), P/E Ratio (N/A vs 40.4x), Revenue Growth (-0.1% vs 0.4%), Gross Margin (32.5% vs 83.0%).

Popular Stock Comparisons